2025³â 08¿ù 06ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92490°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

ÇÑÈ­»ý¸í, ¹Ì±¹ Áõ±Ç»ç º§·Î½ÃƼ Àμö ¿Ï·á

ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®Àå
ÇÑÈ­»ý¸íÀº ¹Ì±¹ Áõ±Ç»ç ‘º§·Î½ÃƼ’ÀÇ ÁöºÐ 75% Àμö ÀýÂ÷¸¦ 30ÀÏ(ÇöÁö½Ã°£) ¼º°øÀûÀ¸·Î ¸¶¹«¸®Çϰí, º¸Çè Áß½ÉÀÇ Æ÷Æ®Æú¸®¿À¸¦ ³Ñ¾î ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®ÀåÀ» º»°ÝÈ­ÇÑ´Ù°í 31ÀÏ ¹àÇû´Ù. À̹ø º§·Î½ÃƼ Àμö´Â ±¹³» º¸Çè»ç°¡ ‘±Û·Î¹ú ÀÚº» ½ÃÀåÀÇ Á߽ɺΒÀÎ ¹Ì±¹ Áõ±Ç ½ÃÀå¿¡ ÁøÃâÇÑ ÃÖÃÊÀÇ »ç·Ê´Ù. À̷νá ÇÑÈ­»ý¸íÀº ¹Ì±¹ ÇöÁö ±ÝÀ¶»ç¸¦ ÅëÇØ ¼öÀͼºÀ» ³ôÀ̰í, ¿ì¼öÇÑ ±Û·Î¹ú ±ÝÀ¶ »óǰÀ» ±Û·Î¹ú °í°´¿¡°Ô Á¦°øÇÒ ¼ö ÀÖ´Â Ç÷§ÆûÀ» ¸¶·ÃÇß´Ù. ´º¿åÀ» °ÅÁ¡À¸·Î ÇÑ º§·Î½ÃƼ´Â ±ÝÀ¶ °Å·¡ ü°á ...
ÁøÄ³½ºÆ®-Á¦³ëÇ︯½º, ¾ÏÀ¯ÀüÀÚ Áø´Ü »ç¾÷È­ MOU (2024-12-22)
ÇÑÈ­»ý¸í ¡®ÇÑÈ­»ý¸í The ½Ã±×´Ïó ¾Ïº¸Ç衯 Ãâ½Ã (2024-11-12)
KGM, µ¿Àý±â Â÷·®Á¡°Ë ¼­ºñ½º ½ÃÇà (2024-12-09)
¼­Ç÷¯½º±Û·Î¹ú, AI Ȱ¿ëÇØ ¹ÝµµÃ¼ Àåºñ ¹× ºÎǰ À¯Åë Çõ½Å (2024-10-30)
»ý¼ºÇü AI ±ÞÁõÀ¸·Î À¥ ¾ÖÇø®ÄÉÀÌ¼Ç ¹× API °ø°Ý 7300°Ç µ¹ÆÄ (2024-10-30)
±¹³» ÃÖ´ë ½Ã»ó±Ý ±Ô¸ð¡¦ Á¦1ȸ »ïÀÍ ¾Æ¸¶Ãß¾î ÄáÄí¸£ (2024-10-17)
¹è¿ì ¹®Áø½Â, ¿µÈ­ ¡®µ¿È­Áö¸¸ ûºÒÀÔ´Ï´Ù¡¯ ÀÔ¼Ò¹® ÁÖ¿ª (2025-02-01)
¡®´Ïµ·³»»ê µ¶¹ÚÅõ¾î3¡¯, 2025³â »õÇØ¸ÂÀÌ Ã¹ ±¹³» ¿©Çà (2025-02-01)
ÆÛ½Ã½º±×·ì, Å䯮³Ñ Ȫ½ºÆÛ FC¿Í °ø½Ä ÆÄÆ®³Ê½Ê °è¾à (2024-11-13)
ÀüÀÚ½Ä »çÀ̵å¹Ì·¯ ½Ã½ºÅÛ MAN ¿ÉƼºä ÀåÂø ¶óÀξ÷ È®´ë (2024-12-10)
Çö´ëÂ÷¡¤±â¾Æ, ¼¼°è ÃÖÃÊ ÇÁ·¹½º ±ÝÇü ¼³°è ÀÚµ¿È­ ½Ã½ºÅÛ °³¹ß (2024-10-18)
50% of Asia Pacific Organizations Experience IT or Business ... (2025-03-27)
The LYCRA Company Previews Bio-Derived LYCRA¢ç EcoMade Fiber... (2024-12-11)
ÀâÄÚ¸®¾Æ, ¡®Ãë¾÷ÅåÅ塯 °Ô½Ã±Û 9¸¸ 9õ°Ç µ¹ÆÄ (2024-11-15)
Schwab, Georgieva Discuss ¡®New Era¡¯ of Global Transformati... (2025-03-01)
Takeda and Nature Announce Call for Applications Now Open fo... (2025-06-15)
ÇÑÀü, RPA Ȱ¿ëÇØ Àü±â¿ä±Ý º¹ÁöÇÒÀÎ ÀڰݰËÁõ ÀÚµ¿È­ (2024-11-02)
Merz Aesthetics Reveals Global Data on the Connection Betwee... (2025-02-16)
¿¡À̼ö½º, Àü¹®°¡ À§ÇÑ ±×·¡ÇÈÄ«µå 5Á¾ Ãâ½Ã (2024-02-12)
½´³ªÀÌ´õ ÀÏ·ºÆ®¸¯ ÄÚ¸®¾Æ, ¡®À̳뺣ÀÌ¼Ç µ¥ÀÌ 2024¡¯ °³ÃÖ (2024-10-07)
°³¹ß»ç¾÷°ø°£ ºÐ¼® ¹× »ç¾÷ºñ º¸°í¼­ »ý¼º ÀÚµ¿È­ (2022-11-20)
»ï»ç¶ó ¿¡ÄÚ-NILIT, ¼¼°è ÃÖÃÊ ³ªÀÏ·Ð 6,6 ÀçȰ¿ë ½Ã¼³ ±¸Ãà Çù... (2024-08-29)
¡®³ª´Â SOLO¡¯ 22±â, µ¹½ÌµéÀÇ ÃÖÈÄÀÇ ¼±ÅÃÀº? (2024-10-21)
HDÇö´ëÁß°ø¾÷, Çʸ®ÇÉ ÃÖ´ë ¹æ»êÀü½Ãȸ Âü°¡ (2024-09-25)
¡®¿ì¸®ÇÔ²² ´õ Äɾ ½ÃÁð2 ½ÃÀÛ (2024-12-13)
       [ÀÌÀü][1]....[365][366][367][368][369][370][371][372][373]...[3700][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..